David F Ackerley Selected Research

David F Ackerley Research Topics

13	Neoplasms (Cancer) 04/2024 - 01/2006
4	Hypoxia (Hypoxemia) 02/2022 - 08/2013
2	Infections 01/2023 - 01/2020
2	Carcinoma (Carcinomatosis) 04/2021 - 04/2013
2	Disease Progression 03/2017 - 10/2015
1	Chronic Disease (Chronic Diseases) 04/2023
1	Malaria 01/2023
1	Hyperglycemia 01/2023
1	Necrosis 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021
1	Retinal Diseases 01/2021
1	Abscess 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Tuberculosis (Tuberculoses) 07/2015
1	Starvation 10/2011

15	ProdrugsIBA 04/2024 - 01/2006
10	EnzymesIBA 01/2021 - 01/2006
9	NitroreductasesIBA 04/2024 - 04/2013
4	PR-104AIBA 02/2022 - 08/2013
2	Phosphates (Orthophosphate)IBA 02/2022 - 01/2016
2	4-nitroimidazoleIBA 01/2021 - 01/2019
2	tretazicarIBA 01/2021 - 02/2018
2	SN33623IBA 01/2021 - 01/2019
1	Metronidazole (Metric)FDA LinkGeneric 04/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	mRNA VaccinesIBA 01/2023
1	VaccinesIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	vadimezanIBA 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2021
1	Oxidoreductases (Dehydrogenase)IBA 11/2021
1	Plicamycin FDA Link 04/2021
1	Neuroprotective AgentsIBA 01/2021
1	salicylanilideIBA 01/2020
1	Colistin (Coly-Mycin)FDA Link 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Niclosamide FDA Link 01/2020
1	azomycinIBA 01/2019
1	PR-104IBA 01/2016
1	SN34507IBA 01/2016
1	SN35539IBA 01/2016
1	Isoniazid (Ftivazide)FDA LinkGeneric 07/2015
1	Oxygen (Dioxygen)IBA 08/2013
1	Proteins (Proteins, Gene)FDA Link 04/2013
1	achromobactinIBA 10/2011
1	IronIBA 10/2011
1	pyoverdinIBA 10/2011
1	SiderophoresIBA 10/2011

10	Therapeutics 04/2024 - 04/2013
1	Drug Therapy (Chemotherapy) 01/2006